Back to results
CompletedPhase 3

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

NCT03901105

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

American College of Radiology

Philadelphia, Pennsylvania, United States

View on ClinicalTrials.gov
Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease — TrialFind